🇺🇸 FDA

Intelligence · Patent portfolio

Jazz Pharmaceuticals Ireland Patents

Full USPTO pharma patent portfolio for Jazz Pharmaceuticals Ireland — grant dates, expiration, and drug cross-links.

Patents
89
Expiring ≤24m
0

Quick answer

Jazz Pharmaceuticals Ireland has 89 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 2

  1. US 12427160

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12403136

    Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12396963

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12383512

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12383567

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12364670

    Cannabidiol-type cannabinoid compound

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12350253

    Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12318356

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12304912

    Fused bicyclic RAF inhibitors and methods for use thereof

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12263139

    Use of cannabidiol in the treatment of tuberous sclerosis complex

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12213985

    Oral cannabinoid formulations

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12161620

    Devices and methods for facilitating and controlling use of a medication

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12161607

    Combination of cannabinoids in the treatment of leukemia

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12138233

    Methods of treating idiopathic hypersomnia

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12121571

    Recombinant L-asparaginase

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12102619

    Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12064398

    Parenteral formulations

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12064399

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11986446

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11980636

    Treatment of hematological disorders

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11858930

    Fused bicyclic RAF inhibitors and methods for use thereof

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11802279

    Modified L-asparaginase

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11571440

    Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11554102

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11426373

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11413264

    Carbamoyl phenylalaninol analogs and uses thereof

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11400052

    Alcohol-resistant drug formulations

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11364215

    GHB formulation and method for its manufacture

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11253494

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11207270

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11160779

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11147782

    GHB formulation and method for its manufacture

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11149000

    Carbamoyl phenylalaninol compounds and uses thereof

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11090269

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11077079

    GHB formulation and method for its manufacture

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11072579

    Treatment of cataplexy

    Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11046946

    PEGylated L-asparaginase

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11033530

    Devices and methods for facilitating and controlling use of a medication

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10987310

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10966931

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10959956

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10959976

    Methods and compositions for treating excessive sleepiness

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10940133

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10912754

    Methods and compositions for treating excessive sleepiness

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10864181

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10829443

    Solvate form of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10813885

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Jazz Pharmaceuticals Ireland have?

89 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Jazz Pharmaceuticals Ireland patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.